These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22074611)

  • 1. Reply to: Implicit memory in schizophrenia: the problem that will not go away.
    Weickert TW
    Biol Psychiatry; 2012 Mar; 71(6):e17; discussion e19, e21. PubMed ID: 22074611
    [No Abstract]   [Full Text] [Related]  

  • 2. Procedural learning in schizophrenia: reconciling the discrepant findings.
    Gomar JJ; Pomarol-Clotet E; Sarró S; Salvador R; Myers CE; McKenna PJ
    Biol Psychiatry; 2011 Jan; 69(1):49-54. PubMed ID: 20817152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorimotor and cognitive performance of schizophrenic inpatients treated with haloperidol, flupenthixol, or clozapine.
    Classen W; Laux G
    Pharmacopsychiatry; 1988 Nov; 21(6):295-7. PubMed ID: 2907629
    [No Abstract]   [Full Text] [Related]  

  • 4. Frontal lobe tasks, antipsychotic medication, and schizophrenia syndromes.
    Himelhoch S; Taylor SF; Goldman RS; Tandon R
    Biol Psychiatry; 1996 Feb; 39(3):227-9. PubMed ID: 8837987
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
    Dittert S; Soyka M; Winter C; Möller HJ
    Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of clozapine and risperidone on spatial working memory in schizophrenia.
    McGurk SR; Carter C; Goldman R; Green MF; Marder SR; Xie H; Schooler NR; Kane JM
    Am J Psychiatry; 2005 May; 162(5):1013-6. PubMed ID: 15863811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine.
    Stip E; Remington GJ; Dursun SM; Reiss JP; Rotstein E; MacEwan GW; Chokka PR; Jones B; Dickson RA;
    J Clin Psychopharmacol; 2003 Aug; 23(4):400-4. PubMed ID: 12920417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative psychomotor dysfunction in schizophrenia: a loss of drive, impaired movement execution or both?
    Docx L; Sabbe B; Provinciael P; Merckx N; Morrens M
    Neuropsychobiology; 2013; 68(4):221-7. PubMed ID: 24247207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL; Harris MS; Keshavan MS; Sweeney JA
    Arch Gen Psychiatry; 2006 Nov; 63(11):1189-97. PubMed ID: 17088499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of haloperidol and atypical neuroleptics on psychomotor performance and driving ability in schizophrenic patients. Results from an experimental study.
    Kagerer S; Winter C; Möller HJ; Soyka M
    Neuropsychobiology; 2003; 47(4):212-8. PubMed ID: 12824745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Learning and generalization in schizophrenia: effects of disease and antipsychotic drug treatment.
    Shohamy D; Mihalakos P; Chin R; Thomas B; Wagner AD; Tamminga C
    Biol Psychiatry; 2010 May; 67(10):926-32. PubMed ID: 20034612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychomotor performance of schizophrenic patients and long-term neuroleptic therapy].
    Burr W; Kaiser E
    Psychiatr Clin (Basel); 1983; 16(5-6):316-23. PubMed ID: 6139845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A failure of sleep-dependent procedural learning in chronic, medicated schizophrenia.
    Manoach DS; Cain MS; Vangel MG; Khurana A; Goff DC; Stickgold R
    Biol Psychiatry; 2004 Dec; 56(12):951-6. PubMed ID: 15601605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia.
    McGurk SR; Green MF; Wirshing WC; Wirshing DA; Marder SR; Mintz J; Kern R
    Schizophr Res; 2004 Jun; 68(2-3):225-33. PubMed ID: 15099605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia.
    Reilly JL; Harris MS; Khine TT; Keshavan MS; Sweeney JA
    Biol Psychiatry; 2007 Oct; 62(7):818-21. PubMed ID: 17300756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine force instability: a quantitative measure of neuroleptic-induced dyskinesia in the hand.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1990; 2(4):395-8. PubMed ID: 1983784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered interleukin-3 serum levels in drug-naïve and neuroleptic-treated schizophrenic patients.
    Xiu MH; Chen S; Wang F; Cao LY; Qi LY; Chen DC; Wu GY; Lu L; Kosten TA; Kosten TR; Zhang XY
    Schizophr Res; 2008 Dec; 106(2-3):369-70. PubMed ID: 18838250
    [No Abstract]   [Full Text] [Related]  

  • 18. Clozapine improves working memory updating in schizophrenia.
    Galletly CA; Clark CR; McFarlane AC
    Eur Neuropsychopharmacol; 2005 Dec; 15(6):601-8. PubMed ID: 15905072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of D2- and D4-blocking neuroleptics on the procedural learning of schizophrenic patients.
    Bédard MA; Scherer H; Delorimier J; Stip E; Lalonde P
    Can J Psychiatry; 1996 Sep; 41(7 Suppl 1):S21-4. PubMed ID: 8884048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients.
    Kirsch P; Ronshausen S; Mier D; Gallhofer B
    Pharmacopsychiatry; 2007 Sep; 40(5):196-8. PubMed ID: 17874350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.